Abbott said it is extending its tender offer to stockholders to sell their Series B Convertible Perpetual Preferred Stock in Alere Inc.
Abbott said in a release it will buy the stock for $402 a share, as well as the cost of dividends that had added up for stockholders but had not been given to them.
Abbott said it is extending the offer as part of an earlier agreement to acquire Alere, medical diagnostic test manufacturer. Abbott began buying Alere stock on July 17 and was going to close the offer on Aug. 11 but instead has extended the offer to Aug. 31.
